BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 26265416)

  • 1. Polycystic ovary syndrome and metabolic syndrome.
    Ali AT
    Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and metabolic disorders: A review of the literature.
    Ali AT; Al-Ani O; Al-Ani F; Guidozzi F
    Afr J Reprod Health; 2022 Aug; 26(8):89-99. PubMed ID: 37585035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical cardiovascular disease and polycystic ovary syndrome.
    Gomez JMD; VanHise K; Stachenfeld N; Chan JL; Merz NB; Shufelt C
    Fertil Steril; 2022 May; 117(5):912-923. PubMed ID: 35512975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midlife women's health consequences associated with polycystic ovary syndrome.
    Ali AT; Guidozzi F
    Climacteric; 2020 Apr; 23(2):116-122. PubMed ID: 31657237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic consequences of polycystic ovary syndrome.
    Churchill SJ; Wang ET; Pisarska MD
    Minerva Ginecol; 2015 Dec; 67(6):545-55. PubMed ID: 26372304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical implications of polycystic ovary syndrome].
    Dravecká I
    Vnitr Lek; 2016; 62(5):392-7. PubMed ID: 27319232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
    De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
    Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.
    Teede H; Deeks A; Moran L
    BMC Med; 2010 Jun; 8():41. PubMed ID: 20591140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary (Stein-Leventhal) syndrome: etiology, complications, and treatment.
    Hoyt KL; Schmidt MC
    Clin Lab Sci; 2004; 17(3):155-63. PubMed ID: 15314890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.
    Krentowska A; Kowalska I
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3464. PubMed ID: 33988288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of obesity in the development of polycystic ovary syndrome.
    Motta AB
    Curr Pharm Des; 2012; 18(17):2482-91. PubMed ID: 22376149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of polycystic ovary syndrome: a practical guide.
    Stankiewicz M; Norman R
    Drugs; 2006; 66(7):903-12. PubMed ID: 16740005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
    Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.